Integration analysis of lncRNA and mRNA expression data identifies DOCK4 as a potential biomarker for elderly osteoporosis
-
Published:2024-03-05
Issue:1
Volume:17
Page:
-
ISSN:1755-8794
-
Container-title:BMC Medical Genomics
-
language:en
-
Short-container-title:BMC Med Genomics
Author:
Wu Chengai,Wang Chao,Xiao Bin,Li Shan,Sheng Yueyang,Wang Qianqian,Tao Jianfeng,Zhang Yanzhuo,Jiang Xu
Abstract
Abstract
Background
We aimed to identify some potential biomarkers for elderly osteoporosis (OP) by integral analysis of lncRNA and mRNA expression data.
Methods
A total of 8 OP cases and 5 healthy participants were included in the study. Fasting peripheral venous blood samples were collected from individuals, and total RNA was extracted. RNA-seq library was prepared and sequenced on the Illumina HiSeq platform. Differential gene expression analysis was performed using “DESeq2” package in R language. Functional enrichment analysis was conducted using the “clusterProfiler” package, and the cis- and trans-regulatory relationships between lncRNA and target mRNA were analyzed by the lncTar software. A protein-protein interaction (PPI) network was constructed using the STRING database, and hub genes were identified through the MCODE plugin in Cytoscape.
Results
We identified 897 differentially expressed lncRNAs (DELs) and 1366 differentially expressed genes (DEGs) between normal and OP samples. After co-expression network analysis and cis-trans regulatory genes analysis, we identified 69 candidate genes regulated by lncRNAs. Then we further screened 7 genes after PPI analysis. The target gene DOCK4, trans-regulated by two lncRNAs, was found to be significantly upregulated in OP samples. Additionally, 4 miRNAs were identified as potential regulators of DOCK4. The potential diagnostic value of DOCK4 and its two trans-regulatory lncRNAs was supported by ROC analysis, indicating their potential as biomarkers for OP.
Conclusion
DOCK4 is a potential biomarker for elderly osteoporosis diagnostic. It is identified to be regulated by two lncRNAs and four miRNAs.
Funder
Beijing Municipal Health Commission
Beijing Natural Science Foundation - Haidian Original Innovation Joint Fund
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Nih Consensus Development Panel on Osteoporosis Prevention, D. and Therapy, Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285(6): 785-95. https://doi.org/10.1001/jama.285.6.785.
2. Osteoporosis. Available from: https://www.niams.nih.gov/health-topics/osteoporosis.
3. Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56. https://doi.org/10.5152/eurjrheum.2016.048.
4. Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, et al. Osteoporosis: a review of treatment options. P T. 2018;43(2):92–104.
5. Tucci JR. Importance of early diagnosis and treatment of osteoporosis to prevent fractures. Am J Manag Care. 2006;12(7 Suppl):S181-90.